PHAXIAM Therapeutics S.A. (PHXM) — Long-term Investment Intensity
PHAXIAM Therapeutics S.A. (PHXM) has a Long-term Investment Intensity of 0.0% as of December 2020. Long-term investments of €17.00K represent 0.0% of total assets of €80.40 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how aggressively does PHAXIAM Therapeutics S.A. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
PHAXIAM Therapeutics S.A. Long-term Investment Intensity (2017–2020)
This chart shows how PHAXIAM Therapeutics S.A.'s Long-term Investment Intensity has evolved across 4 annual periods from 2017 to 2020. As of December 2020, the intensity stands at 0.0%, reflecting long-term investments of €17.00K against total assets of €80.40 Million EUR. Explore PHXM operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for PHAXIAM Therapeutics S.A. (2017–2020)
The table below presents the year-by-year Long-term Investment Intensity for PHAXIAM Therapeutics S.A. from 2017 to 2020, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see PHXM market cap.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2020 | 0.0% | €17.00K | €80.40 Million | ▲ +0.0 pp |
| 2019 | 0.0% | €17.00K | €118.55 Million | ▼ 0.0 pp |
| 2018 | 0.1% | €91.00K | €167.84 Million | ▲ +0.0 pp |
| 2017 | 0.0% | €66.00K | €195.26 Million | — |